Importantly, antimiR-218-5p reverses these effects by reducing Wnt activity and expression of both PTHrP and Rankl, thereby attenuating the oncogenic and osteolytic properties of metastatic breast cancer cells. The gene discussed is PTHLH; the disease is breast carcinoma.